Tag Archives: LumiraDx’s Point of Care Technology

Roche Completes Acquisition of LumiraDx’s Point of Care Technology, Enhancing Global Diagnostic Capabilities

(IN BRIEF) Roche has completed the acquisition of LumiraDx’s Point of Care technology after receiving all necessary antitrust and regulatory clearances. This addition enhances Roche’s diagnostics portfolio with an advanced multi-assay platform that consolidates a wide range of tests, including … Read the full press release